Jim Pepin

Consigliere Generale presso LEGEND BIOTECH CORPORATION

Health Technology

Consumer Services

Profilo

Jim Pepin is currently the General Counsel at Legend Biotech Corp.
Prior to his current position, he served as the Secretary, Senior Vice President & General Counsel at Aimmune Therapeutics, Inc. from 2020 to 2023.
Before that, he was the Vice President & General Counsel at Nestlé Health Science (Deutschland) GmbH from 2010 to 2020.
Mr. Pepin obtained his undergraduate degree from the University of Virginia in 1997 and his graduate degree from the University of Virginia School of Law in 2001.

Posizioni attive di Jim Pepin

Società	Posizione	Inizio
LEGEND BIOTECH CORPORATION	Consigliere Generale	01/11/2023

Tutte le posizioni attive di Jim Pepin

Precedenti posizioni note di Jim Pepin

Società	Posizione	Fine
AIMMUNE THERAPEUTICS, INC.	Consigliere Generale	01/11/2023
Nestlé Health Science (Deutschland) GmbH Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk.	Consigliere Generale	01/10/2020

Vedi nel dettaglio l'esperienza di Jim Pepin

Formazione di Jim Pepin

University of Virginia	Undergraduate Degree
University of Virginia School of Law	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jim Pepin

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
LEGEND BIOTECH CORPORATION	Health Technology

Aziende private	2
Aimmune Therapeutics, Inc. Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.	Health Technology
Nestlé Health Science (Deutschland) GmbH Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk.	Health Technology